An ambitious European research project funded through the European Union H2020 scheme and aimed at finding a new treatment for ALS (motor neurone disease, MND) is testing a molecule that occurs naturally in our bodies and helps to regulate our immune system.
ALS (Amyotrophic Lateral Sclerosis) is the most common motor neuron disease, also known as Lou Gehrig’s disease. It is a devastating condition associated with degeneration of upper and lower motorneurons resulting in a fatal outcome within 1-5 years, with no significantly effective treatment available to date. ALS Centres in Europe have established ENCALS as a network to collaborate in their research for a cure of ALS.
The ENCALS satellite meeting 2015 will be held at December 10th, prior to the 25th MND conference in Orlando, USA. The meeting will be from 13.30 to 17.00. The focus of the meeting will be on multicentre collaborative research projects (biomarkers, harmonization of procedures, validation of outcome measures, study results etc.) Please send your abstract to email@example.com before November 10th. Please find more information on the meeting page.
Twitter using hashtag #ENCALS